
Medwella Pharmaceuticals Private Limited
About Medwella Pharmaceuticals Private Limited
Data last updated:
Medwella Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 29 January 2024.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U21001MH2024PTC418083.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abdul Rub Shaikh Abdul Gaffar Shaikh and Sheikh Saddam Sheikh Nizam.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagpur, Maharashtra.
Company details
Contact details
Medwella Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressHouse No. 473, Gittikhadan Chowk, Nagpur, Maharashtra, India – 440013
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medwella Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Medwella Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medwella Pharmaceuticals Private Limited
Medwella Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdul Rub Shaikh Abdul Gaffar Shaikh Also directs: Nyloz Pharmaceutical Private Limited | Director | 29 Jan 2024 | 2 Years 9 Months | Current |
| Sheikh Saddam Sheikh Nizam | Director | 29 Jan 2024 | 2 Years 9 Months | Current |
| Shaikh Sadique Shaikh Matin | Director | 29 Jan 2024 | 2 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Medwella Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medwella Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medwella Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medwella Pharmaceuticals Private Limited has 3 board changes on record since 2024: 3 appointments. The latest: Abdul Rub Shaikh Abdul Gaffar Shaikh was appointed as Director on 29 Jan 2024.
Frequently asked questions
Medwella Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 29 January 2024 (2+ years old) and is registered under CIN U21001MH2024PTC418083.
Medwella Pharmaceuticals has 3 current directors:
- Abdul Rub Shaikh Abdul Gaffar Shaikh - Director
- Sheikh Saddam Sheikh Nizam - Director
- Shaikh Sadique Shaikh Matin - Director
The latest financial statements of Medwella Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Medwella Pharmaceuticals is U21001MH2024PTC418083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medwella Pharmaceuticals was incorporated on 29 January 2024, making it 2+ years old. It is registered with the Registrar of Companies, Nagpur.
Abdul Rub Shaikh Abdul Gaffar Shaikh was appointed as Director on 29 Jan 2024. Shaikh Sadique Shaikh Matin was appointed as Director on 29 Jan 2024. Sheikh Saddam Sheikh Nizam was appointed as Director on 29 Jan 2024.
The registered office of Medwella Pharmaceuticals is at House No. 473, Gittikhadan Chowk, Nagpur, Maharashtra, India – 440013.
Medwella Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Medwella Pharmaceuticals can be reached at its registered office: House No. 473, Gittikhadan Chowk, Nagpur, Maharashtra, India – 440013.
Medwella Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Nagpur.

